The DMα and DMβ chain cooperate in the oxidation and folding of HLA-DM

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5430-5439

  Van Lith, Marcel ^a   Benham, Adam M ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLYCOSIDASE H; GLYCOSIDASE; HLA DM ANTIGEN; HOMODIMER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; DISULFIDE; HLA D ANTIGEN; HLA DMB; HLA-DMB; OXYGEN; PEPTIDE; PROTEIN SUBUNIT;

ANTIGEN PRESENTING CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISULFIDE BOND; ENDOPLASMIC RETICULUM; ENDOSOME; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LYSOSOME; OXIDATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; WESTERN BLOTTING; CELL CULTURE; CHEMISTRY; GLYCOSYLATION; IMMUNOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN TRANSPORT;

ANTIGEN-PRESENTING CELLS; CELLS, CULTURED; DISULFIDES; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HELA CELLS; HLA-D ANTIGENS; HUMANS; OXIDATION-REDUCTION; OXYGEN; PEPTIDES; PROTEIN FOLDING; PROTEIN SUBUNITS; PROTEIN TRANSPORT;

EID: 33749514979     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5430     Document Type: Article

References (52)

1. Benham, A., A. Tulp, and J. Neefjes. 1995. Synthesis and assembly of MHC-peptide complexes. Immunol. Today 16: 359-362.
2. Galvin, K., S. Krishna, F. Ponchel, M. Frohlich, D. E. Cummings, R. Carlson, I. R. Wands, K. I. Isselbacher, S. Pillai, and M. Ozturk. 1992. The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene. Proc. Natl. Acad. Sci. USA 89: 8452-8456.
3. Ahluwalia, N., J. J. Bergeron, I. Wada, E. Degen, and D. B. Williams. 1992. The p88 molecular chaperone is identical to the endoplasmic reticulum membrane protein, calnexin. J. Biol. Chem. 267: 10914-10918.
4. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5: 103-114.
5. + T-cell immune responses? Immunol. Rev. 207: 77-88.
6. Roche, P. A., M. S. Marks, and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354: 392-394.
7. Lamb, C. A., and P. Cresswell. 1992. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148: 3478-3482.
8. Roche, P. A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345: 615-618.
9. Teyton, L., D. O'Sullivan, P. W. Dickson, V. Lotteau, A. Sette, P. Fink, and P. A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348: 39-44.
10. Schaiff, W. T., K. A. Hruska, Jr., D. W. McCourt, M. Green, and B. D. Schwartz. 1992. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J. Exp. Med. 176: 657-666.
11. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63: 707-716.
12. Riberdy, J. M., J. R. Newcomb, M. J. Surman, J. A. Barbosa, and P. Cresswell. 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360: 474-477.
13. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375: 802-806.
14. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82: 155-165.
15. van Ham, S. M., U. Gruneberg, G. Malcherek, I. Broker, A. Melms, and J. Trowsdale. 1996. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 184: 2019-2024.
16. Fling, S. P., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368: 554-558.
17. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368: 551-554.
18. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84: 531-541.
19. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84: 543-550.
20. Fung-Leung, W. P., C. D. Surh, M. Liljedahl, I. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271: 1278-1281.
21. van Ham, M., M. van Lith, A. Griekspoor, and J. Neefjes. 2000. What to do with HLA-DO? Immunogenetics 51: 765-770.
22. Marks, M. S., P. A. Roche, E. van Donselaar, L. Woodruff, P. J. Peters, and J. S. Bonifacino. 1995. A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments. J. Cell Biol. 131: 351-369.
23. Copier, J., M. J. Kleijmeer, S. Ponnambalam, V. Oorschot, P. Potter, J. Trowsdale, and A. Kelly. 1996. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB. J. Immunol. 157: 1017-1027.
24. Anderson, K. S., and P. Cresswell. 1994. A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO J. 13: 675-682.
25. Arunachalam, B., and P. Cresswell. 1995. Molecular requirements for the interaction of class II major histocompatibility complex molecules and invariant chain with calnexin. J. Biol. Chem. 270: 2784-2790.
26. Miyazaki, J., E. Appella, and K. Ozato. 1986. Intracellular transport blockade caused by disruption of the disulfide bridge in the third external domain of major histocompatibility complex class I antigen. Proc. Natl. Acad. Sci. USA 83: 757-761.
27. Smith, J. D., J. C. Solheim, B. M. Carreno, and T. H. Hansen. 1995. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and β2-microglobulin. Mol. Immunol. 32: 531-540.
28. Warburton, R. J., M. Matsui, S. L. Rowland-Jones, M. C. Gammon, G. E. Katzenstein, T. Wei, M. Edidin, H. J. Zweerink, A. J. McMichael, and J. A. Frelinger. 1994. Mutation of the α2 domain disulfide bridge of the class I molecule HLA-A*0201: effect on maturation and peptide presentation. Hum. Immunol. 39: 261-271.
29. Wilkinson, B., and H. F. Gilbert. 2004. Protein disulfide isomerase. Biochim. Biophys. Acta 1699: 35-44.
30. Tu, B. P., S. C. Ho-Schleyer, K. J. Travers, and J. S. Weissman. 2000. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science 290: 1571-1574.
31. Frand, A. R., and C. A. Kaiser. 1999. Ero1p oxidizes protein disulfide isomerase in a pathway for disulfide bond formation in the endoplasmic reticulum. Mol. Cell. 4: 469-477.
32. Cabibbo, A., M. Pagani, M. Fabbri, M. Rocchi, M. R. Farmery, N. J. Bulleid, and R. Sitia. 2000. ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum. J. Biol. Chem. 275: 4827-4833.
33. Pagani, M., M. Fabbri, C. Benedetti, A. Fassio, S. Pilati, N. J. Bulleid, A. Cabibbo, and R. Sitia. 2000. Endoplasmic reticulum oxidoreductin 1-Iβ (ERO1-Lβ), a human gene induced in the course of the unfolded protein response. J. Biol. Chem. 275: 23685-23692.
34. Benham, A. M., A. Cabibbo, A. Fassio, N. Bulleid, R. Sitia, and I. Braakman. 2000. The CXXCXXC motif determines the folding, structure and stability of human Ero1-Lα. EMBO J. 19: 4493-4502.
35. van Lith, M., M. van Ham, A. Griekspoor, E. Tjin, D. Verwoerd, J. Calafat, H. Janssen, E. Reits, L. Pastoors, and J. Neefjes. 2001. Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 167: 884-892.
36. van Ham, M., M. van Lith, B. Lillemeier, E. Tjin, U. Gruneberg, D. Rahman, L. Pastoors, K. van Meijgaarden, C. Roucard, J. Trowsdale, et al. 2000. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)- DO. J. Exp. Med. 191: 1127-1136.
37. Wubbolts, R., M. Fernandez-Borja, L. Oomen, D. Verwoerd, H. Janssen, J. Calafat, A. Tulp, S. Dusseljee, and J. Neefjes. 1996. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J. Cell Biol. 135: 611-622.
38. Busch, R., R. C. Doebele, E. von Scheven, J. Fahrni, and E. D. Mellins. 1998. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function. J. Immunol. 160: 734-743.
39. Shackelford, D. A., and J. L. Strominger. 1983. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens. J. Immunol. 130: 274-282.
40. Sanderson, F., C. Thomas, J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4: 87-96.
41. Molinari, M., and A. Helenius. 2000. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288: 331-333.
42. Deprez, P., M. Gautschi, and A. Helenius. 2005. More than one glycan is needed for ER glucosidase II to allow entry of glycoproteins into the calnexin/calreticulin cycle. Mol. Cell 19: 183-195.
43. Arnold, J. N., C. M. Radcliffe, M. R. Wormald, L. Royle, D. J. Harvey, M. Crispin, R. A. Dwek, R. B. Sim, and P. M. Rudd. 2004. The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J. Immunol. 173: 6831-6840.
44. Mosyak, L., D. M. Zaller, and D. C. Wiley. 1998. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9: 377-383.
45. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184: 2153-2165.
46. Guerra, C. B., R. Busch, R. C. Doebele, W. Liu, T. Sawada, W. W. Kwok, M. D. Chang, and E. D. Mellins. 1998. Novel glycosylation of HLA-DRα disrupts antigen presentation without altering endosomal localization. J. Immunol. 160: 4289-4297.
47. Kleizen, B., and I. Braakman. 2004. Protein folding and quality control in the endoplasmic reticulum. Curr. Opin. Cell. Biol. 16: 343-349.
48. Daniels, R., B. Kurowski, A. E. Johnson, and D. N. Hebert. 2003. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell 11: 79-90.
49. Wujek, P., E. Kida, M. Walus, K. E. Wisniewski, and A. A. Golabek. 2004. N-glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I. J. Biol. Chem. 279: 12827-12839.
50. Cannon, K. S., and P. Cresswell. 2001. Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J. 20: 2443-2453.
51. Kleizen, B., T. van Vlijmen, H. R. de Jonge, and I. Braakman. 2005. Folding of CFTR is predominantly cotranslational. Mol. Cell 20: 277-287.
52. Land, A., D. Zonneveld, and I. Braakman. 2003. Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage. FASEB J. 17: 1058-1067.